Top news of the week: 29.07.2021.
Career And Jobs
Strengthening the Biopharma Ecosystem through Startup-Corporate Collaboration
Over the past decade, we’ve seen seismic shifts in the way large life sciences companies and startups work together. From simply viewing small businesses as acquisition targets to the ...
Good Day BIO: Senate talks ag biotech and pandemic preparedness
From ag biotech in Mexico, to pandemic preparedness in the U.S., it was a busy day on Capitol Hill yesterday as BIO’s Dr. Michelle McMurry-Heath and Phyllis Arthur testified on these ...
Create Value & Success Will Follow, Anima Biotech CEO Yochi Slonim Says
“When big pharma collaborates with biopharma companies, the main risk isn’t the technology, but the commitment of the partner,” according to serial entrepreneur Yochi Slonim, CEO of Anima ...
Amgen bellies back up to the M&A table for another biotech buyout, this time with a $2.5B deal for an antibody player focused on PSMA
Five months after Amgen CEO Bob Bradway stepped up to the M&A table and acquired Five Prime for $1.9 billion, following up with the smaller Rodeo acquisition, he’s gone back in for another ...
GSK and Vir Biotechnology announce Joint Procurement Agreement with European Commission for COVID-19 treatment, sotrovimab
GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced they have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of sotrovimab, an ...
The BioMidwest Region Features Lifestyle Bonuses and Cutting-Edge Science
Why not take advantage of the perks of a lower cost of living, slower pace, and opportunities to make a big impact in some important disease areas?
Life Sciences Companies Throwing Money into Facility Expansions and Jobs
There has been a flurry of expansion activity in the life sciences industry as biopharma and diagnostic companies expand manufacturing sites. Here’s a look.
Denali slips as a snapshot of early data raises some troubling questions on its pioneering blood-brain barrier neuro work
Denali Therapeutics had drummed up considerable hype for their blood-brain barrier technology since launching over six years ago, hype that’s only intensified in the last 14 months ...